SARS-CoV-2 IgG ELISA Kit, Nucleocapsid – Witec AG

Art No | K-16026-001
1'150.00 CHF
1'150.00 CHF
Brochure

Size: 1 Kit

The ELISA assays are designed for the qualitative measurement of human IgG, immunoglobulin that is produced in response to an antigen, against the Nucleocapsid or Spike (RBD) proteins from the SARS-CoV-2 virus.

Description

Advansta now offers recombinant forms of the Nucleocapsid and Spike Receptor Binding Domain (RBD) proteins encoded by the virus as well as ELISA kits to detect the IgG immune response to both the Nucleocapsid and Spike (RBD) proteins.

Each protein is expressed in Escherichia coli or CHO K1 cells and affinity purified.

Each ELISA kit contains a high binding ELISA plate, a recombinant SARS-CoV-2 protein, Positive and Negative Control Serum, 1X EIA Coating Buffer, AdvanBlock-EIA, Anti-Human IgG HRP Conjugate, TMB Substrate and Stop Solution sufficient to perform one 96-well colorimetric ELISA assay.

SARS-CoV-2 ELISA Kits contain everything you need to conveniently measure the lgG immune response against the SARS-CoV-2 Nucleocapsid or Spike (RBD) proteins in COVID-19 positive or immunized patients.

Evaluation of IgG humoral immune response by ELISA to recombinant SARS-CoV-2 target proteins in negative and COVID-19 positive serum samples.

Supplier

Advansta Inc.
show all products

Related products

If you continue we assume that you consent to receive all cookies on this website. More information

My Cart